| Year | Citation | Score | |||
|---|---|---|---|---|---|
| 2021 | Mitrano DA, Houle SE, Pearce P, Quintanilla RM, Lockhart BK, Genovese BC, Schendzielos RA, Croushore EE, Dymond EM, Bogenpohl JW, Grau HJ, Webb LS. Olfactory dysfunction in the 3xTg-AD model of Alzheimer's disease. Ibro Neuroscience Reports. 10: 51-61. PMID 33842910 DOI: 10.1016/j.ibneur.2020.12.004 | 0.425 | |||
| 2017 | Ritter-Makinson SL, Paquet M, Bogenpohl JW, Rodin RE, Chris Yun C, Weinman EJ, Smith Y, Hall RA. Group II Metabotropic Glutamate Receptor Interactions with NHERF Scaffold Proteins: Implications for Receptor Localization in Brain. Neuroscience. PMID 28392297 DOI: 10.1016/J.Neuroscience.2017.03.060 | 0.506 | |||
| 2013 | Bogenpohl J, Galvan A, Hu X, Wichmann T, Smith Y. Metabotropic glutamate receptor 4 in the basal ganglia of parkinsonian monkeys: ultrastructural localization and electrophysiological effects of activation in the striatopallidal complex. Neuropharmacology. 66: 242-52. PMID 22634360 DOI: 10.1016/J.Neuropharm.2012.05.017 | 0.465 | |||
| 2012 | Bogenpohl JW, Ritter SL, Hall RA, Smith Y. Adenosine A2A receptor in the monkey basal ganglia: ultrastructural localization and colocalization with the metabotropic glutamate receptor 5 in the striatum. The Journal of Comparative Neurology. 520: 570-89. PMID 21858817 DOI: 10.1002/Cne.22751 | 0.422 | |||
| 2011 | Masilamoni GJ, Bogenpohl JW, Alagille D, Delevich K, Tamagnan G, Votaw JR, Wichmann T, Smith Y. Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys. Brain : a Journal of Neurology. 134: 2057-73. PMID 21705423 DOI: 10.1093/Brain/Awr137 | 0.444 | |||
| Show low-probability matches. | |||||